Davis Polk & Wardwell and Cleary Gottlieb Steen & Hamilton’s City arms have taken lead roles on Agilent’s $2.2bn (£1.4bn) acquisition of Danish cancer diagnostics company Dako from private equity house EQT Partners.
New York firm Davis Polk, which advised longstanding client EQT, fielded a London and New York-based team led by City-based US-qualified corporate partner Jeffrey O’Brien. New York of counsel Stephen Pepper provided antitrust advice with New York partner Neil Barr advising on tax matters. Danish independent Kromann Reumert advised Agilent on Danish law.
